Free Trial

Oscar Health, Inc. (NYSE:OSCR) Director Sells $426,250.00 in Stock

Oscar Health logo with Finance background

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now owns 89,512 shares of the company's stock, valued at $1,526,179.60. This trade represents a 21.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Oscar Health Stock Performance

NYSE OSCR traded down $0.33 on Friday, hitting $15.98. 5,071,729 shares of the stock were exchanged, compared to its average volume of 3,423,949. The business's fifty day moving average is $18.01 and its 200 day moving average is $18.23. Oscar Health, Inc. has a 52 week low of $7.29 and a 52 week high of $23.79. The company has a market capitalization of $3.95 billion, a PE ratio of -271.79 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business's quarterly revenue was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.29) EPS. Research analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently made changes to their positions in OSCR. Sei Investments Co. increased its position in Oscar Health by 100.0% during the 1st quarter. Sei Investments Co. now owns 42,998 shares of the company's stock worth $639,000 after purchasing an additional 21,497 shares in the last quarter. ProShare Advisors LLC lifted its stake in shares of Oscar Health by 10.9% in the 1st quarter. ProShare Advisors LLC now owns 28,950 shares of the company's stock valued at $430,000 after purchasing an additional 2,842 shares during the period. Vanguard Group Inc. grew its position in shares of Oscar Health by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company's stock worth $216,846,000 after buying an additional 337,850 shares during the period. American International Group Inc. boosted its position in shares of Oscar Health by 1.3% during the 1st quarter. American International Group Inc. now owns 79,411 shares of the company's stock worth $1,181,000 after purchasing an additional 1,009 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Oscar Health in the 1st quarter worth about $2,230,000. Institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

OSCR has been the subject of a number of research reports. Piper Sandler restated an "overweight" rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Oscar Health currently has an average rating of "Moderate Buy" and an average target price of $22.93.

Read Our Latest Report on Oscar Health

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Articles

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Oscar Health right now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

AVGO is up 30% since earnings: could Broadcom be the next member of the Magnificent Seven? Can it sustain this momentum or is a pullback on the horizon?

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines